GT Biopharma Inc (GTBP) — Cash Flow Reinvestment Rate
Latest as of September 2014:
0.00x
GT Biopharma Inc (GTBP) has a Cash Flow Reinvestment Rate of 0.00x as of September 2014, reinvesting $2.00 (capex $2.00 ) from operating cash flow of $45.00K. Check GT Biopharma Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$2.00
Capex + Investments
Operating Cash Flow
$45.00K
USD
Capital Expenditures
$2.00
USD
GT Biopharma Inc Cash Flow Reinvestment Rate (1987–1994)
Historical reinvestment intensity for GT Biopharma Inc across 5 annual periods. Explore GTBP operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for GT Biopharma Inc (1987–1994)
Year-by-year capital reinvestment analysis for GT Biopharma Inc. For live market cap and broader valuation context, see GTBP stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 1994 | 0.00x | $0.00 | $400.00K | $0.00 | — |
| 1990 | 0.00x | $0.00 | $900.00K | $0.00 | — |
| 1989 | 0.00x | $0.00 | $700.00K | $0.00 | — |
| 1988 | 0.00x | $0.00 | $100.00K | $0.00 | ▼ -100.0% |
| 1987 | 1.00x | $50.00K | $50.00K | $50.00K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow